Torx logo

Torx

Hypothesis-driven small molecule design and synthesis tracking for collaborative drug discovery DMTA cycles.

Visit website

Overview

Torx® Software is a collaborative platform purpose-built for hypothesis-driven small molecule discovery chemistry. Born from a partnership between Cresset® and Elixir™ Software, Torx provides medicinal chemists and discovery teams with an integrated environment to make better design decisions and track compound synthesis from start to finish across the full DMTA (Design, Make, Test, Analyze) cycle.

The platform is designed to serve teams working in small molecule drug discovery, enabling seamless collaboration across all roles involved in the DMTA workflow — from computational and medicinal chemists to synthetic chemists and biologists — ensuring that critical project information is always accessible and actionable.

Torx Design & Analyze

  • Enhances molecule design by providing access to all key project information in one place
  • Enables teams to analyze design outcomes to drive inspiration and informed decision making
  • Supports hypothesis-driven approaches to small molecule design, helping teams prioritize and refine compound ideas based on data

Torx Make & Test

  • Combines design information and assay results in a single click to inform the next round of the development cycle
  • Streamlines the connection between synthetic chemistry execution and biological testing data
  • Helps teams close the loop between compound synthesis and experimental outcomes, accelerating iterative cycles

Integrated DMTA Workflow

  • Covers the complete Design, Make, Test, and Analyze cycle within a unified platform
  • Facilitates collaboration between Cresset's computational chemistry expertise and Elixir Software's compound and assay management capabilities
  • Designed to reduce friction between discovery chemistry disciplines and improve the speed and quality of decision making throughout a project

Torx® Software brings together the strengths of two established life sciences software providers to deliver a cohesive, end-to-end solution for small molecule discovery teams seeking to optimize their DMTA workflows and accelerate the path from hypothesis to candidate compound.